Sweeney & Michel, LLC Pfizer Inc Transaction History

Sweeney & Michel, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $182,550 - $209,626	-7,051 Reduced 45.15%	8,566 $243 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $298,051 - $348,392	-9,288 Reduced 37.29%	15,617 $481 Million
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $144 - $167	-4 Reduced 0.02%	24,905 $888 Million
Q1 2023 Jun 07, 2023	BUY	$39.39 - $51.28 $981,165 - $1.28 Million	24,909 New	24,909 $956 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Sweeney & Michel, LLC, based on Form 13F filings with the SEC.

Stay updated on Sweeney & Michel, LLC with notifications on news.